American Journal of Epidemiology Advance Access published online on October 11, 2006
American Journal of Epidemiology, doi:10.1093/aje/kwj333
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 General Internal Medicine Section, San Francisco VA Medical Center, San Francisco, CA
* To whom correspondence should be addressed. Most studies of the relation between kidney function and physical function have been conducted in persons with advanced kidney disease and have used creatinine-based measures of kidney function. Cystatin C concentration is a measure of kidney function that is independent of muscle mass, unlike creatinine. Using baseline data on 3,043 elderly adults from the Health, Aging, and Body Composition Study (Blacks and Whites recruited from Pittsburgh, Pennsylvania, and Memphis, Tennessee, in 1997-1998), the authors examined the cross-sectional association between cystatin C level and performance on several tests of physical function. After adjustment for demographic and lifestyle variables, chronic health conditions, and inflammation, each standard-deviation (0.34 mg/liter) increase in cystatin C concentration was associated with 1.32 odds (95% confidence interval (CI): 1.20, 1.46) of not completing a 400-m walk, a 10.9-second (95% CI: 8.1, 13.8) slower 400-m walk time, a 0.11-point (95% CI: 0.09, 0.13) reduction in lower extremity performance score, a 1.12-kg (95% CI: 0.83, 1.40) lower grip strength, and a 4.7-nm (95% CI: 3.5, 5.9) lower knee extension strength. In contrast, when kidney function was measured by estimated glomerular filtration rate, the association of kidney function with physical function was only evident below 60 ml/minute/1.73 m2. In these older adults, mild decrements in kidney function, as measured by cystatin C concentration, were associated with poorer physical function.
Received March 10, 2006
Accepted May 2, 2006
ORIGINAL CONTRIBUTIONS
Cystatin C and Measures of Physical Function in Elderly Adults
Michelle C. Odden 1, Glenn M. Chertow 2, Linda F. Fried 3, Anne B. Newman 4, Stephanie Connelly 5, Sara Angleman 5, Tamara B. Harris 5, Eleanor M. Simonsick 5, and Michael G. Shlipak 6 *, for the HABC Study
2 Department of Nephrology, University of California, San Francisco, San Francisco, CA
3 Department of Epidemiology, University of Pittsburgh School of Medicine, Pittsburgh, PA; Renal Section, Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, PA
4 Department of Epidemiology, University of Pittsburgh School of Medicine, Pittsburgh, PA
5 National Institute on Aging, National Institutes of Health, Bethesda, MD
6 General Internal Medicine Section, San Francisco VA Medical Center, San Francisco, CA; Departments of Medicine, Epidemiology, and Biostatistics, University of California, San Francisco, San Francisco, CA
Michael G. Shlipak, E-mail: shlip{at}itsa.ucsf.edu
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. C. Odden, M. G. Shlipak, and I. B. Tager Serum Creatinine and Functional Limitation in Elderly Persons J Gerontol A Biol Sci Med Sci, March 1, 2009; 64A(3): 370 - 376. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Rifkin, M. G. Shlipak, R. Katz, L. F. Fried, D. Siscovick, M. Chonchol, A. B. Newman, and M. J. Sarnak Rapid Kidney Function Decline and Mortality Risk in Older Adults Arch Intern Med, November 10, 2008; 168(20): 2212 - 2218. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lin and G. C. Curhan Kidney function decline and physical function in women Nephrol. Dial. Transplant., September 1, 2008; 23(9): 2827 - 2833. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Weiner, H. Tighiouart, E. F. Elsayed, J. L. Griffith, D. N. Salem, and A. S. Levey Uric Acid and Incident Kidney Disease in the Community J. Am. Soc. Nephrol., June 1, 2008; 19(6): 1204 - 1211. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Schwartz, E. Vittinghoff, D. E. Sellmeyer, K. R. Feingold, N. d. Rekeneire, E. S. Strotmeyer, R. I. Shorr, A. I. Vinik, M. C. Odden, S. W. Park, et al. Diabetes-Related Complications, Glycemic Control, and Falls in Older Adults Diabetes Care, March 1, 2008; 31(3): 391 - 396. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Guralnik Successful Aging: Is It in Our Future? Arch Intern Med, January 28, 2008; 168(2): 131 - 132. [Full Text] [PDF] |
||||
![]() |
M. C. Odden, R. Scherzer, P. Bacchetti, L. A. Szczech, S. Sidney, C. Grunfeld, and M. G. Shlipak Cystatin C Level as a Marker of Kidney Function in Human Immunodeficiency Virus Infection: The FRAM Study Arch Intern Med, November 12, 2007; 167(20): 2213 - 2219. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Singh, M. A. Whooley, J. H. Ix, S. Ali, and M. G. Shlipak Association of cystatin C and estimated GFR with inflammatory biomarkers: the Heart and Soul Study Nephrol. Dial. Transplant., April 1, 2007; 22(4): 1087 - 1092. [Abstract] [Full Text] [PDF] |
||||




